Billing experts and lawmakers are playing catch-up as providers get around new consumer protections, leaving patients like Danielle Laskey of Washington state with big bills for emergency care.
When a dire disease strikes, it's easy to slip into war terms to describe the experience. But that sort of talk turns life into two outcomes: winning and losing. And that's not the way life works.
People leaving jail or prison are at extremely high risk of hospitalization and death, and policymakers from deep blue California to solidly red Utah think bringing Medicaid behind bars could help.
Archaeologists have discovered evidence of a rare type of skull surgery dating back to the Bronze Age that's similar to a procedure still being used today.
Two stroke patients regained control of a disabled arm and hand after researchers delivered electrical stimulation to their spines, paving the way toward a medical device that could aid movement.
Florida's medical boards have voted to ban gender-affirming care for transgender youth. Families with trans children and medical providers who care for them are worried about the impact.
Marburg virus is hard to detect early on--and goes on to kill about half its victims. Researchers hope to work quickly during this outbreak to make progress on emerging vaccines and treatments.
Researchers paired new parents with financial coaches in a pediatric clinic. They found the families were more likely to come for well-child visits and vaccinations — and they got ahead financially.
A man with uncontrolled epileptic seizures sought surgery in 2009, but was turned down. Ten years later, advances in neurodiagnostic testing, lasers and microelectronics finally helped him.
Medicare suddenly stopped paying for the pricey drug that prolongs his life. As he waits for an appeal, this retired physician wonders if he should give up treatment to spare his family the cost.
She's seen what happens when people don't trust or understand their doctor. Dr. Lisa Fitzpatrick founded 'Grapevine Health' to get solid information out, especially to Black and Latinx patients.
Drugmakers will be required to pay Medicare back for price increases that outpace inflation. The industry is expected to put up a fight over implementation.
Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.
The main reason the surge is ebbing now, pandemic experts suspect, is the significant immunity many people in the U.S. have acquired from prior infections and COVID vaccinations many received.
